Hiroyo Ninomiya

Identification of Metabolites Associated with Onset of CAD in Diabetic Patients Using CE-MS Analysis: A Pilot Study

Kazuo Omori, Naoto Katakami, Yuichi Yamamoto et al. · Journal of Atherosclerosis and Thrombosis · 2018 · 32 citations · Full text

Life Sciences, Biochemistry, Cardiology +17

Skin autofluorescence is associated with vascular complications in patients with type 2 diabetes

Saeko Osawa, Naoto Katakami, Ihoko Sato et al. · Journal of Diabetes and its Complications · 2018 · 31 citations

Medicine, Dermatology, Endocrinology +12

Association between Subclinical Atherosclerosis Markers and the Level of Accumulated Advanced Glycation End-Products in the Skin of Patients with Diabetes

Hiroyo Ninomiya, Naoto Katakami, Ihoko Sato et al. · Journal of Atherosclerosis and Thrombosis · 2018 · 31 citations · Full text

Medicine, Endocrinology, Internal Medicine +16

Identification of Plasma Inositol and Indoxyl Sulfate as Novel Biomarker Candidates for Atherosclerosis in Patients with Type 2 Diabetes. -Findings from Metabolome Analysis Using GC/MS-

Kazuo Omori, Naoto Katakami, Shoya Arakawa et al. · Journal of Atherosclerosis and Thrombosis · 2020 · 25 citations · Full text

Life Sciences, Biochemistry, Cardiology +17

The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus

Naoto Katakami, Tomoya Mita, Hidenori Yoshii et al. · Diabetes Therapy · 2021 · 23 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17